International Horizon Scanning Initiative Moves Forward
An initiative that will improve payers’ ability to negotiate prices for disruptive new drugs is closer to fruition.
You may also be interested in...
Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.
The Netherlands calls for multi-country price negotiations for gene therapy Zynteglo.
The Valletta Group says that cancer drugs, treatments for autoimmune diseases, orphan medicines and biosimilars are among the products it is targeting in its joint procurement efforts.